Intriguingly, HPX, a confirmed regulator of large intestinal aging and gut barrier integrity, emerged as a predictor of prognosis in patients with CRC over 50 years of age but not in patients younger than 50 years of age (Extended Data Fig. 7h,i), indicating that an age-associated increase in HPX might contribute to cancer progression. This evidence concerns the gene HPX and colorectal carcinoma.